Steady-state methadone in rats does not change mRNA levels of corticotropin-releasing factor, its pituitary receptor or proopiomelanocortin

European Journal of Pharmacology

Volumn 315, Issue 1, 1996, Pages 31-35

  Zhou, Yan ^a   Spangler, Rudolph ^a   Maggos, Christopher E ^a   LaForge, K Steven ^a   Ho, Ann ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Corticosterone; CRF (corticotropin releasing factor) CRF type 1 receptor; Methadone; POMC (proopiomelanocortin); Solution hybridization

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; HORMONE RECEPTOR; MESSENGER RNA; METHADONE; OPIATE AGONIST; OPIATE RECEPTOR; PROOPIOMELANOCORTIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; DRUG EFFECT; GENE EXPRESSION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; INFUSION PUMPS, IMPLANTABLE; MALE; METHADONE; NARCOTICS; PITUITARY GLAND, ANTERIOR; PITUITARY-ADRENAL SYSTEM; PRO-OPIOMELANOCORTIN; RATS; RATS, INBRED F344; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER;

EID: 0030574235     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00672-3     Document Type: Article

References (19)

1. Borg, L., A. Ho, J.E. Peters and M.J. Kreek, 1995, Availability of reliable serum methadone determination for management of symptomatic patients, J. Addict. Dis. 14, 83.
2. Bronstein, D.M., R. Przewlocki and H. Akil, 1990, Effects of morphine treatment on pro-opiomelanocortin systems in rat brain, Brain Res. 519, 102.
3. Buckingham, J.C. and T.A. Cooper, 1984, Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine, Neuroendocrinology 38, 411.
4. Civelli, O., N. Birnberg and E. Herbert, 1982, Detection and quantitation of pro-opiomelanocortin mRNA in pituitary and brain tissues from different species, J. Biol. Chem. 257, 6783.
5. Dole, V.P., M.E. Nyswander and M.J. Kreek, 1966, Narcotic blockade, Arch. Intern. Med. 118, 304.
6. Ignar, D.M. and C.M. Kuhn. 1990, Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat, J. Pharmacol. Exp. Ther. 225, 1287.
7. Kreek, M.J., 1973, Medical safety and side effects of methadone in tolerant individuals, J. Am. Med. Ass. 223, 665.
8. Kreek, M.J., 1979, Methadone disposition during the perinatal period in human, Pharmacol. Biochem. Behav. 11, 7.
9. Kreek, M.J., S.L. Wardlaw and N. Hartman, 1983, Circadian rhythms and levels of beta-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans, Life Sci. 33, 409.
10. Kreek, M.J., J. Raghunath, S. Plevy, D. Hamer, B. Schneider and N. Hartman, 1984, ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans, Neuropeptides 5, 277.
11. Lamberts, S.W.J., E.N.W. Janssen, E.G. Bons, P. Uitterlinden, J.M. Zuierwijk and E. Del Pozo, 1983, The met-enkephalin analogue FK 33824 directly inhibits ACTH release by the rat pituitary gland in vitro, Life Sci. 32, 1167.
12. Lightman, S.L. and W.S. Young III, 1988, Corticotropin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat, J. Physiol. 403, 511.
13. McDonald, R.K., F.T. Evans, V.K. Weise and R.W. Patrick, 1959, Effect of morphine and nalorphine on plasma hydrocortisone levels in man, J. Pharmacol. Exp. Ther. 125, 241.
14. Plotsky, P.M., 1986, Opioid inhibition of immunoreactive corticotropin-releusing factor secretion into the hypophysial-portal circulation of rats, Regul. Pept. 16, 235.
15. Potter, E., S. Sutton, C. Donaldson, R. Chen, M. Perrin, K. Lewis, P.E. Sawchenko and W. Vale, 1994, Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary, Proc. Natl. Acad. Sci. USA 91, 8777.
16. Ragavan, V.V., S.L. Wardlaw, M.J. Kreek and A.G. Frantz, 1983, Effect of chronic naltrexone and methadone administration on brain immunoreactive β-endorphin in the rat, Neuroendocrinology 37, 266.
17. Zhou, Y., R. Spangler. K.S. LaForge, C.E. Maggos, A. Ho and M.J. Kreek, 1996a, Modulation of CRF-R1 mRNA in rat anterior pituitary by dexamethasone: Correlation with POMC mRNA, Peptides 17, 435.
18. Zhou, Y., R. Spangler, K.S. LaForge, C.E. Maggos. A. Ho and M.J. Kreek, 1996b, Corticotropin-releasing factor and CRF-R1 mRNAs in rat brain and pituitary during 'binge' pattern cocaine administration and chronic withdrawal, J. Pharmacol. Exp. Ther., in press.
19. Ziring, B.S., M.J. Kreek and L.T. Brown, 1981, Methadone disposition following oral and parenteral drug administration in rats during chronic treatment. Drug Alcohol Depend. 7, 311.